PTK2B (PYK2) is a non-receptor protein tyrosine kinase that serves as a critical mechanosensitive signaling hub with diverse roles in immune cell function, cancer progression, and neurodegeneration. The protein functions as an immunomechanical checkpoint that governs monocyte-to-macrophage differentiation by sensing mechanical signals through PIEZO1 and integrins, triggering F-actin polymerization and nuclear translocation to regulate mechanotransduction genes 1. In pancreatic cancer, PTK2B deletion impairs macrophage differentiation and enhances anti-PD-1 immunotherapy efficacy 1. PTK2B is implicated in multiple disease contexts: it represents a significant genetic risk factor for Alzheimer's disease, with variants affecting inflammatory pathways in brain endothelial and immune cells 23. Notably, an Alzheimer's disease risk variant enhances PTK2B expression in brain CD8 T cells, providing genetic evidence for adaptive immunity in disease pathogenesis 3. The gene also shows kinase-activating alterations in Philadelphia chr8-like acute lymphoblastic leukemia, where PTK2B fusions contribute to poor prognosis 45. Additionally, PTK2B expression correlates with obesity-related parameters in children and adolescents, suggesting metabolic regulatory functions 6. Overall, PTK2B emerges as a key mediator linking mechanical sensing to immune cell differentiation and multiple disease pathologies.